Global Apheresis Equipment Market 2016-2024: Rising Adoption of Therapeutic and Donor Apheresis Favors Growth

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Apheresis Equipment in US$ Thousand by the following Type of Apheresis Equipment:

The Global market is additionally analyzed by the following Procedures:

The report profiles 14 companies including many key and niche players such as:

Key Topics Covered:

1. INDUSTRY OVERVIEW
-  Apheresis Equipment - Rising Adoption of Therapeutic and Donor Apheresis Favors Growth
-  Donor Apheresis & Therapeutic Apheresis
-  Donor Apheresis: Dominating Equipment Sales
-  Therapeutic Apheresis to Witness Strong Growth
-  Disposable Apheresis Kits Market Benefits from Single-Use Nature of Products
-  Centrifugation Technology Continues to Lead, Membrane Filtration Promises Growth
-  Plasmapheresis Systems Dominate Apheresis Equipment Market
-  Neurology - The Major Application Area for Apheresis Equipment
-  Developed Markets Continue to Lead Apheresis Equipment Market
-  Developing Nations to Lead the Charge in Future
-  Rising Demand for Plasma from Biopharmaceutical Companies
-  Opportunity to Tap
-  Sustained Growth in Blood Collections Favors Apheresis Equipment Market
-  Competitive Landscape
-  Consolidation of Blood Collectors & Healthcare Providers Puts Pricing Pressure on Suppliers

2. KEY MARKET TRENDS & DRIVERS
-  Rising Cancer Incidence to Drive Volume of Apheresis Procedures
-  Technological Advancements and Novel Indications Augur Well for Apheresis Market
-  Blood Supply Shortage & Safety Concerns Bode Well for Apheresis Market
-  Photopheresis: A Popular Therapeutic Apheresis Procedure
-  Plasmapheresis Continues to Lead the Apheresis Market
-  Plateletpheresis Emerges as the Treatment of Choice'
-  Increase in Number of Platelet Donors Drives Apheresis Procedures
-  Pediatrics: An Unexplored Domain in Therapeutic Apheresis
-  Automated Blood Processing Systems in Open Heart Surgeries
-  CFA - An Effective Way to Pull Up Cold Hemagglutinin Disease
-  Improving Healthcare Expenditure to Drive Demand
-  Aging Population: A Strong Growth Driver
-  Key Challenges & Issues
-  Lack of Awareness among Patients Restrains Market Growth
-  Vendors' Attitude Hampers Growth Prospects of Therapeutic Apheresis
-  Development of Inexpensive Apheresis Therapies
-  Shortage of Qualified Donors
-  Challenges for Therapeutic Apheresis in the Unexplored Pediatrics Segment

3. TECHNOLOGY OVERVIEW
-  Apheresis - The Definition
-  Apheresis Vs Whole Blood Collection
-  Comparison of Apheresis and Whole Blood Collection
-  The Process of Apheresis - An Overview
-  Blood Components
-  Apheresis Procedure
-  Duration, Frequency, and Efficiency of Apheresis
-  Segregation of Blood Components
-  Centrifugation
-  Centrifugal Cell Separators
-  Filtration
-  Side Effects
-  Types of Apheresis Procedures
-  Plasmapheresis
-  Plasma Exchange and Plasmapheresis: The Difference
-  Therapeutic Plasma Exchange (TPE) or Plasma Exchange
-  TPE: Abnormal Components Removed from Blood
-  Plasmapheresis: Potential Uses Discovered in the Early Years
-  Potential Use of Plasmapheresis in Select Diseases Discovered in the Early Years
-  Erythrocytapheresis
-  Plateletpheresis
-  Leukapheresis
-  Photopheresis
-  Functioning of THERAKOS - A Typical Photopheresis System
-  Lipidpheresis
-  Cytapheresis
-  Stem Cell Collection
-  Apheresis - A Review of Segmentation
-  Donor Apheresis
-  Process of Donor Apheresis
-  Automated Blood Donation Procedures
-  Safety of the Donor
-  Blood Components Required by Different Patients
-  Automated Apheresis
-  Therapeutic Apheresis: An Introduction
-  Therapeutic Apheresis Techniques
-  Applications of Therapeutic Apheresis
-  Categories of Indications for Therapeutic Apheresis
-  Therapeutic Apheresis is Remedial for Various Diseases
-  Indications for Therapeutic Apheresis
-  Type of Therapeutic Apheresis Procedure Used in Different Medication Conditions
-  Emerging Applications of Therapeutic Apheresis
-  Cost of Select Therapeutic Apheresis Procedures: An Overview
   1. Photopheresis in GVHD (Graft-Versus-Host Disease)
   2. Lipid Apheresis (LDL Apheresis)
   3. Plasmapheresis and Other Procedures
-  Therapeutic Apheresis: What is the Risk Involved?
-  Replacement Fluid in Therapeutic Apheresis
-  Replacement Fluids Used in Therapeutic Apheresis
-  Various Replacement Fluids in Use
-  Select Replacement Fluids and their Limitations
-  Complications Involved and Suggested Treatment in the Therapeutic Apheresis Procedure
-  Therapeutic Plasmapheresis with Fresh Frozen Plasma (FFP) Replacement

4. BLOOD COMPONENTS & DERIVATIVES
-  Red Blood Cells (RBCs)
-  White Blood Cells (WBCs)
-  Platelets
-  Sources of Blood Plasma
-  Facts About Plasma and its Donation
-  Pre-requisites for Plasma Donors
-  The Complex Process of Becoming a Donor
-  Medical Screening
-  The Process of Plasma Donation
-  Select IQPP-authorized Plasma Collection Centers (US)
-  Ionic Composition of Blood
-  Types of Blood
-  General Facts about Blood
-  General Uses of Blood
-  Blood - Global Facts

5. PRODUCT INNOVATIONS/INTRODUCTIONS
-  Fresenius Introduces 6008 CAREsystem
-  Terumo BCT Launches Correct Connect System
-  FDA Approves IDE Supplement for Cerus' INTERCEPT Blood System
-  Health Canada Approves WBCD and PMN Cell Collection Protocols for Spectra Optia
-  USFDA Clears PMN Protocol for Terumo's Spectra Optia

6. RECENT INDUSTRY ACTIVITY
-  Haemonetics Gains FDA Approval for NexSys PCS Plasmapheresis System
-  Terumo BCT Receives CE Mark for Spectra Optia Apheresis System
-  Terumo BCT Enters into Distribution Agreement with B Medical Systems
-  Mallinckrodt Takes Over Therakos
-  HemaCare Sells Therapeutic Apheresis Assets to Fresenius
-  Terumo BCT Files FDA Submission to Improve Blood Supply Safety
-  Fenwal Autopheresis-C Instruments Donated for Ebola Virus Study
-  Terumo opens Production Facility in Vietnam
-  Terumo Collaborates with Kaneka
-  Terumo to Distribute Therakos Products in Latin America
-  Terumo Enters Distribution Agreement with Therakos

7. FOCUS ON SELECT PLAYERS
-  Asahi Kasei Medical Co., Ltd. (Japan)
-  B Braun Melsungen AG (Germany)
-  Cerus Corporation (USA)
-  Fresenius Kabi (Germany)
-  Haemonetics Corporation (USA)
-  Kaneka Corporation (Japan)
-  Kawasumi Laboratories, Inc. (Japan)
-  Mallinckrodt Pharmaceuticals (Ireland)
-  Medica SpA (Italy)
-  NIKKISO Europe GmbH (Germany)
-  Terumo BCT, Inc. (USA)

8. GLOBAL MARKET PERSPECTIVE

For more information about this report visit https://www.researchandmarkets.com/research/mc4r97/apheresis

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716